Singapore Medical Group

CLINIC operator Singapore Medical Group may implement a formal dividend policy in fiscal 2019 along with a share buyback mandate as part of its plan to enhance shareholder value. This comes after the group recently completed a strategic review of its operations.

The firm will continue to explore growth initiatives with the potential for earnings-accretive mergers and acquisitions. To facilitate the scaling of its overseas operations, it intends to commit S$3 million to grow each of these business ventures, including those in Vietnam and Indonesia. It also has plans to enter Malaysia.